Peer-reviewed studyPNAS
Immune T cells drive nerve damage in human brain organoids
A peer-reviewed study in human brain organoids (lab models of brain tissue) found that CD8-positive T cells, a type of immune cell, drove injury to neurons when amyloid-beta, a protein linked to Alzheimer's disease, was present. The T cells were drawn in through the CX3CL1–CX3CR1 axis, and neutralizing their cytokines and cytotoxic molecules rescued the tissue.
- Published
- Oct 20, 2026
DOI 10.1073/pnas.2605209123
Peer-reviewed studyPLOS Medicine
Blood protein scores may refine cardiovascular risk assessment
A peer-reviewed cohort study in PLOS Medicine tested protein risk scores for atherosclerosis progression, meaning the worsening of artery disease, in a community population. Added to a guideline-recommended traditional risk score, the scores reclassified 18.6% of intermediate-risk individuals into the high-risk category. The authors say the scores need larger external validation before wider use.
- Published
- Oct 20, 2026
DOI 10.1371/journal.pmed.1005265
Preprint, not peer-reviewedChemRxiv
Researchers map the atomic structure of a drug held in a polymer
A preprint on ChemRxiv, not yet reviewed by other scientists, reports the first complete three-dimensional, atomic-level structure of an amorphous solid dispersion, a drug (AZD5462) mixed into a copovidone polymer. The authors say the polymer reshapes the hydrogen-bonding network, which may explain why the formulation stayed physically stable for over two years while the pure drug recrystallized within hours.
- Published
- Oct 20, 2026
DOI 10.26434/chemrxiv.15010694/v1
Preprint, not peer-reviewedmedRxiv
Gut microbiome changes persist after stroke and may respond to probiotics
A preprint on medRxiv, not yet reviewed by other scientists, found that gut microbiota changes after ischemic stroke persisted for up to three months in two patient cohorts and in experimental models. In a randomized, double-blind trial, a multispecies probiotic led to microbiome changes and significantly improved functional recovery compared with placebo, and the authors call for larger Phase III trials to validate it.
- Published
- Oct 20, 2026
DOI 10.64898/2026.10.15.26365107
Preprint, not peer-reviewedbioRxiv
A naturally occurring microbe may suppress malaria parasites in wild mosquitoes
A preprint on bioRxiv, not yet reviewed by other scientists, followed a symbiont called Microsporidia MB in wild Anopheles arabiensis mosquitoes in western Kenya over 30 months. The authors report that infection was associated with approximately 50% lower odds of Plasmodium falciparum infection, and approximately 60% lower odds for high-intensity symbiont infections.
- Published
- Oct 20, 2026
DOI 10.64898/2026.10.16.759541
Preprint, not peer-reviewedbioRxiv
Nasal swab may beat blood tests for Alzheimer's, a preprint reports
A preprint on bioRxiv, not yet reviewed by other scientists, describes a method that collects neuron-rich cells from the nose with a soft brush swab and measures phosphorylated tau with single-cell Western blotting. The authors report that for Alzheimer's disease this approach had superior diagnostic capacity compared with blood-based approaches.
- Published
- Oct 20, 2026
DOI 10.64898/2026.10.18.759991
Preprint, not peer-reviewedmedRxiv
Long sleep and insomnia linked to lower cognitive function, a preprint finds
A preprint on medRxiv, not yet reviewed by other scientists, pooled three cohort studies with 11,563 participants and found that long sleep, 9 hours or more, and insomnia were associated with lower global cognitive function at baseline. Sleep measures were not associated with change in cognitive function over follow-up, and the authors suggest cognition may be linked to distinct sleep patterns.
- Published
- Oct 20, 2026
DOI 10.64898/2026.10.19.26365906
Peer-reviewed studyPNAS
Brain immune-cell protein 4E-BP shapes survival in an Alzheimer's model
A peer-reviewed PNAS study links cerebrospinal fluid levels of 4E-BP1 to neurodegeneration in amyloid-positive people and shows in mouse microglia that amyloid-beta inactivates 4E-BP1. The authors report that deleting 4E-BP1 and 4E-BP2 increased mitochondrial mass, reduced inflammatory signaling and protected microglia from amyloid-induced cell death.
- Published
- Oct 21, 2026
DOI 10.1073/pnas.2610766123
Peer-reviewed studyPNAS
Genes tied to weight gain in mice also show links to human obesity
A peer-reviewed PNAS study validated some of the genes identified in a companion paper as affecting weight gain on a high-fat diet in male C57BL/6N mice. Tissue-specific inhibition of several of them made the mice resistant to diet-induced obesity or glucose intolerance, and the authors note that eight of the genes were previously implicated in human obesity.
- Published
- Oct 21, 2026
DOI 10.1073/pnas.2613776123
Peer-reviewed studyPLOS Medicine
Simulation study says Shigella vaccine trials may underestimate efficacy
A peer-reviewed simulation study in PLOS Medicine modeled Shigella vaccine trials under different assumptions about natural immunity and trial designs. Only one design, active surveillance for infection with single-outcome models, was consistently unbiased, while the other five could underestimate vaccine efficacy by up to an absolute 20%.
- Published
- Oct 21, 2026
DOI 10.1371/journal.pmed.1004878
Preprint, not peer-reviewedmedRxiv
Clean cookstove trial showed no child growth benefit through age 5
A preprint on medRxiv, not yet reviewed by other scientists, followed children from a randomized trial in which families received a liquefied petroleum gas (LPG) cookstove and free fuel during pregnancy and infancy. Measured at ages 2 to 5 years in India, Rwanda and Guatemala, the study found no statistically significant effect on height-for-age or stunting despite substantial reductions in air pollution during the trial.
- Published
- Oct 21, 2026
DOI 10.64898/2026.10.16.26365712
Peer-reviewed studyCell
MCT6 transporter needed for metformin-linked weight loss in mice
A peer-reviewed Cell study found that the MCT6 transporter is the route by which the metabolite Lac-Phe exits intestinal cells and enters the blood. Mice lacking gut MCT6 could not maintain normal circulating Lac-Phe levels and showed resistance to metformin-associated weight loss.
- Published
- Oct 22, 2026
DOI 10.1016/j.cell.2026.09.058
Preprint, not peer-reviewedbioRxiv
Few predicted tuberculosis antigens are presented by infected cells
A preprint on bioRxiv, not yet reviewed by other scientists, found that fewer than 1% of peptides identified as HLA-A*02:01 binders were detectably presented on MHC class I by human macrophages infected with Mycobacterium tuberculosis. The authors built a neural-network model using gene expression and neighboring amino acids, and used it to identify additional antigens.
- Published
- Oct 22, 2026
DOI 10.64898/2026.10.16.759551
Preprint, not peer-reviewedbioRxiv
Preprint says most low-biomass microbe-disease links fail contamination tests
A preprint on bioRxiv, not yet reviewed by other scientists, argues that many reported microbe-disease associations in low-biomass samples appear to measure sample biomass rather than disease. The authors judged 6,175 claims from 175 studies and propose TRUEDA, a method that reports how much contamination each difference could tolerate before it stops holding.
- Published
- Oct 22, 2026
DOI 10.64898/2026.10.21.760313
Preprint, not peer-reviewedbioRxiv
N-Acetylglucosamine outperformed glucosamine in a rat osteoarthritis study
A preprint on bioRxiv, not yet reviewed by other scientists, compared N-acetylglucosamine with glucosamine hydrochloride in a rat model of knee osteoarthritis. The authors report higher peak serum concentrations, less cartilage degeneration and better results for N-acetylglucosamine, and say it warrants further clinical study.
- Published
- Oct 22, 2026
DOI 10.64898/2026.10.21.760584
Preprint, not peer-reviewedbioRxiv
Excess cell size drives senescence through MDM4 splicing, a preprint reports
A preprint on bioRxiv, not yet reviewed by other scientists, reports that enlarged cells redistribute chromatin between nuclear speckles and the nuclear lamina, which changes gene expression and splice isoform usage. The authors say a non-functional MDM4-S variant blocks G1 cell cycle progression, and that reintroducing correctly spliced MDM4 reverted senescent features in enlarged cells.
- Published
- Oct 22, 2026
DOI 10.64898/2026.10.21.760624
Preprint, not peer-reviewedbioRxiv
Multicellular study of Alzheimer's brain tissue finds a consistent response
A preprint on bioRxiv, not yet reviewed by other scientists, analyzed 2.3 million nuclei from 427 donors to identify multicellular patterns linked to Alzheimer's pathology and sex. The authors report that the pattern included changes in RORB-GABRG excitatory neurons and disrupted oligodendrocyte precursor cell signaling, and that it predicted neuropathology in an independent dataset.
- Published
- Oct 23, 2026
DOI 10.64898/2026.10.19.759610
Preprint, not peer-reviewedmedRxiv
Nairobi COVID-19 patients describe brief, distant care in isolation
A preprint on medRxiv, not yet reviewed by other scientists, is a qualitative study of 15 adults who recovered from COVID-19 after hospital isolation in Nairobi, Kenya, interviewed in 2023. Participants described some attentive care, but also brief and distant contact, unnoticed deterioration and ridicule of distress, and the author proposes fear-driven distancing as an additional form of mistreatment.
- Published
- Oct 23, 2026
DOI 10.64898/2026.10.20.26366069
Preprint, not peer-reviewedbioRxiv
RNF5 tags the TM6SF2 E167K variant for degradation, a preprint reports
A preprint on bioRxiv, not yet reviewed by other scientists, reports that the TM6SF2 E167K variant, a loss-of-function variant linked to metabolic dysfunction-associated steatotic liver disease (MASLD), is recognized and degraded through a cellular protein-degradation pathway. The authors identify RNF5 as the ubiquitin ligase that tags it, and say it provides a rational target for MASLD therapy.
- Published
- Oct 23, 2026
DOI 10.64898/2026.10.21.760790
Preprint, not peer-reviewedmedRxiv
Lipid panels with ApoB may predict heart failure up to 36 months ahead
A preprint on medRxiv, not yet reviewed by other scientists, used electronic health records from the All of Us Research Program to test whether lipid panels that include apolipoprotein B (ApoB) predict a first heart failure event. The authors report an area under the curve (AUC, a measure of prediction accuracy) of 0.624 in men and 0.627 in women for predictions 36 months in advance, and describe LDL cholesterol as a counterintuitive predictor.
- Published
- Oct 24, 2026
DOI 10.64898/2026.10.21.26366145
Preprint, not peer-reviewedmedRxiv
White-matter routing measure may flag Alzheimer's up to four years early
A preprint on medRxiv, not yet reviewed by other scientists, computed a Route Concordance Index from diffusion MRI scans in 1,706 OASIS-3 sessions, and reports that it declined monotonically across a five-stage trajectory. The authors report that a classifier using these routing features detected conversion to mild cognitive impairment (MCI) or Alzheimer's up to four years before diagnosis, and that the findings replicated in a second dataset called ADNI.
- Published
- Oct 24, 2026
DOI 10.64898/2026.10.21.26366165
Preprint, not peer-reviewedbioRxiv
Spatial study finds sex-specific molecular changes across mood disorders
A preprint on bioRxiv, not yet reviewed by other scientists, applied spatial transcriptomics, which maps gene activity within tissue, to the dorsolateral prefrontal cortex of people with major depressive disorder, bipolar disorder and neurotypical controls. The authors report sex- and diagnosis-specific differences in white matter, vascular-linked cell compartments and neurons, including a signaling pathway tied to genetic risk for mood disorders.
- Published
- Oct 24, 2026
DOI 10.64898/2026.10.22.761067
Preprint, not peer-reviewedbioRxiv
Fructose-fed male mice show anxiety that depends on microglia, a preprint says
A preprint on bioRxiv, not yet reviewed by other scientists, gave adult mice 25% fructose in drinking water for 8 weeks and found robust anxiety-like behavior in males, with memory deficits in both sexes. The authors report that knocking down the fructose transporter Glut5 in microglia prevented the anxiety-like behavior, which they say shows microglial fructose uptake is required for it.
- Published
- Oct 24, 2026
DOI 10.64898/2026.10.23.761346